UPDATE : Thursday, July 18, 2019
상단여백
Daewoong joins fray to develop rheumatoid arthritis drug
Daewoong Pharmaceutical said it has begun developing a rheumatoid arthritis...
by Lee Hye-seon  |  2019-06-07 11:29
라인
Ilsan Hospital succeeds in single-port retroperitoneal renal tumor resection
NHIS (National Health Insurance Service) Ilsan Hospital said it has success...
by Song Soo-youn  |  2019-06-05 16:14
라인
Korea’s hospital information system launched at 4th US hospital
A Korean hospital information system called “Best Care 2.0B,” developed by ...
by Choi Gwang-seok  |  2019-06-05 14:59
라인
Pharma industry urges deregulation to develop new drug using AI
The Korean pharmaceutical industry called for the government to ease regula...
by Jeong Sae-im  |  2019-06-05 11:53
라인
[ASCO 2019] 'Ibrance brings hopes to neglected premenopausal breast cancer patients'
CHICAGO, Ill. -- A Korean study has shown that Pfizer's Ibrance extends...
by Lee Han-soo, KBR Corresponden  |  2019-06-05 11:33
라인
[ASCO 2019]'Belvarafenib confirms efficacy for solid cancer without approved treatment'
CHICAGO, Ill. -- Belvarafenib, developed by Hanmi Pharmaceutical, has demon...
by Lee Han-soo, KBR Correspondent  |  2019-06-05 11:29
라인
Seoul holds policy consultation with WHO
The Ministry of Health and Welfare and the delegation from the World Health...
by Kwak Sung-sun  |  2019-06-04 17:35
라인
8 out of 10 Korean doctors wish to leave the country
Eight out of 10 doctors in Korea want to leave for another country to work ...
by Song Soo-youn  |  2019-06-04 15:28
라인
[Special] Doctors skeptical about AI-based precision medicine ‘Dr. Answer’
As IBM’s Watson for Oncology rapidly lost popularity among the local medica...
by Kim Eun-young  |  2019-06-04 14:42
라인
FDA OKs phase-1 trial for Yuhan’s investigational lung cancer drug
Yuhan Corp. is gearing up to develop a new lung cancer drug Lazertinib (YH2...
by Jeong Sae-im  |  2019-06-04 14:21
라인
‘Indoor radon exposure raises tumor mutation in lung cancer patients’
Indoor radon exposure increases tumor gene mutation in non-smoking patients...
by Park Gi-taek  |  2019-06-04 14:19
라인
[ASCO 2019] ‘Ontruzant demonstrates equal quality to original drug’
CHICAGO, Ill. -- Samsung Bioepis has proved its quality control ability, as...
by Lee Han-soo, KBR correspondent  |  2019-06-04 14:17
라인
‘New embolization technique can treat brain aneurysm’
A Korean research team said they found a new embolization technique to trea...
by Kwak Sung-sun  |  2019-06-03 16:23
라인
[ASCO 2019] ‘POLO study opens a new era for treating pancreatic cancer patients’
CHICAGO, Ill. -- AstraZeneca and MSD, also known as Merck & Co. inside the ...
by Lee Han-soo, KBR corresponden  |  2019-06-03 16:18
라인
Kolon’s minority shareholders demand over ₩25 billion in damage
Minority shareholders of Kolon Life Science and its subsidiary Kolon Tissue...
by Jeong Sae-im  |  2019-06-03 14:53
라인
Invossa inventor sold Kolon shares at highest value
Former Kolon TissueGene CEO Lee Kwan-hee, the inventor of now-suspended gen...
by Jeong Sae-im  |  2019-06-03 14:52
라인
[ASCO 2019]Novartis’ Kisqali aims to make comeback with new trial results
CHICAGO, Ill. -- Novartis Kisqali, a cyclin-dependent kinase (CDK) 4/6 inhi...
by Lee Han-soo, KBR correspondent  |  2019-06-03 13:41
라인
[Photo News]Scenes at ASCO 2019
CHICAGO, Ill. -- The American Society of Clinical Oncology (ASCO) 2019 has ...
by Lee Han-soo, KBR correspondent  |  2019-06-03 11:58
라인
[ASCO 2019]Korea expanding presence in global oncology field
CHICAGO, Ill. -- American Society of Clinical Oncology (ASCO) 2019 kicked o...
by Lee Han-soo, KBR correspondent  |  2019-06-03 11:17
라인
[ASCO 2019]Roche CEO unveils his company’s future direction at ASCO 2019
CHICAGO, Ill. -- Roche Pharmaceuticals is one of is the largest healthcare ...
by Lee Han-soo, KBR correspondent  |  2019-06-03 11:09
여백
여백
여백
Back to Top